Skip to content
healthcare.dev

Mag-AL Plus

NDC 0121-1761, Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone, suspension, from PAI Holdings, LLC dba PAI Pharma.

Product NDC
0121-1761
Status
Listed
Labeler
PAI Holdings, LLC dba PAI Pharma
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M001
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0121-1761 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALUMINUM HYDROXIDE1200 mg/30mL
  • MAGNESIUM HYDROXIDE1200 mg/30mL
  • DIMETHICONE120 mg/30mL

Pharmacologic classes

Calculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Skin Barrier Activity [PE]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
0121-1761-300012117613010 TRAY in 1 CASE (0121-1761-30) / 10 CUP, UNIT-DOSE in 1 TRAY / 30 mL in 1 CUP, UNIT-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0121-1761 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0121-1761 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0121-1761. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.